T ERENCE S.

N OVAK
tsnovak@yahoo.com

COMMERCIAL OPERATIONS EXECUTIVE

Sales & Operations Leader | P&L Responsibility | Business Development
Energetic and accomplished senior executive with strong leadership and process improvement skills. Track
record of successful business development in pharmaceutical and biotechnology industries. Strategic problem
solver, ensuring organizational effectiveness by identifying and implementing process improvement
strategies.
Strong leader, skilled at developing relationships with internal and external stakeholders, providing required
information and resolving problems promptly and efficiently.

Business Development
Complex Negotiations
Operational Metrics
Lean Six Sigma Methodology

Global P&L Management

Leadership Development
Relationship Building
Sales Management

Marketing Campaigns
Strategic Planning
Inspirational Leadership
Client Relationships

PROFESSIONAL EXPERIENCE
PERNIX THERAPEUTICS, INC., Morristown, NJ
Chief Operating Officer

March 2014 July 2016

As a member of Executive Team, oversaw day-to-day quality, regulatory, and clinical operations for specialty
pharmaceutical company, designing and implementing business strategies, plans, and procedures.

Coordinated 25 outsourcing relationships and supply chain operations.

Led sales efforts for 35 branded and generic products by contracting with wholesalers and key buying
groups, resulting in positive EBITDA.
Spearheaded due diligence process resulting in acquisition of two branded products.
Drove business to increase profit, repositioning non-promoted product portfolio leading to 20% year
on year sales increase.

NORWICH PHARMACEUTICALS, Norwich, NY

2011 2014
President, Commercial Operations
Recruited by new ownership of contract pharmaceutical development and manufacturing company to grow
revenue and profit.

Improved operational efficiency, developing and executing five-year strategic plan to integrate key
operational and business processes, resulting in six-fold increase in EBITDA after 12 months.
Strengthened marketing and business development efforts leading to four-fold increase in proposals,
100% increase in new business wins, and 28% increase in revenue.
Launched new India-based clinical research division to expand service offerings.

FRONTLINE PHARMACEUTICALS, LLC, Philadelphia, PA

2010 2011
President & CEO (temporary)
Recruited by newly created pharmaceutical company to be operated through acquisition of manufacturing
and product assets.

Led strategic growth initiatives, developing seven-year strategic plan leading to successful round of
financing from major banks.
Developed successful marketing initiatives and business plans, securing $68M in funding to acquire
publicly traded pharmaceutical company.
Forged partnerships with key external stakeholders, forming five-member board of directors.

TERENCE S. NOVAK

(862) 207-1262tsnovak@yahoo.com

PROFESSIONAL EXPERIENCE CONTINUED

PATHEON, RTP, NC
2008 2009
President & Chief Commercial Officer (RTP, NC)
Turned around industry reputation and grew revenue and profit for company in decline due to poor
customer service.

Spearheaded operational and P&L responsibility for $250M pharmaceutical finished-dose contract
manufacturing business in North America, including five manufacturing facilities in the United
States, Canada, and Puerto Rico.
Drove implementation of Lean Six Sigma programs and consistent business metrics at all sites,
developing five-year strategic business plan that improved cost of goods and operational metrics.
Reversed Puerto Rican operations from eight quarters of negative profit to first profitable quarter.
Managed quality improvements, reorganizing sales, marketing, and account management operations
to increase new proposals by 80% and new business awards by 35%.

DSM PHARMACEUTICALS, Parsippany, NJ, Greenville, NC, The Netherlands

2002 2008
President, Business Unit Director, 2007-2008
Promoted to president to spearhead revenue growth and improvement profitability after reorganization
combining commercial and operation executive roles.

Held global operational and P&L responsibility for large and small molecule pharmaceutical contract
manufacturing and development business with 1000 employees and $200M in revenue.
Led multidisciplinary team in developing five-year strategic plan, resulting in increased revenue of
20% and EBITDA of 75%.
Directed strategic growth opportunities, identifying and executing joint venture to develop and
market sterile injectable products.

Executive Vice President & Chief Marketing Officer, 2002-2007

After successfully growing contract manufacturing business, promoted to lead all commercial operations and
serve as member of DSMs pharmaceutical business group Executive Committee.
Held global commercial and P&L responsibility for pharmaceutical and biologic contract
manufacturing business units, responsible for 50% of revenue of 75% of profit.
Established Boston-based biologic contract development joint venture.

Increased overall profitability by 300% over four years.

Prior experience includes positions as senior vice president for DSM Pharmaceuticals, responsible for building newly
created division; vice president of Cytogen Corporation, responsible for developing and executing sales and marketing
plan for oncology business unit; and executive vice president of Algos Pharmaceutical, responsible for start-up pain
management specialty company.

EDUCATION & ACHIEVEMENTS

Bachelor Science, Biology, Muhlenberg College, Allentown, PA
Awards
Board of Directors (2009-2013) Frontline Pharmaceuticals
Board of Directors (2011-2012) Curaxis Pharmaceuticals
Editorial Advisory Board - Contract Pharma magazine
Bristol Myers Squibb - R. D. Keim Award and five-time winner of top sales & management award